RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for 107452-89-1:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- USES: Ziconotide is indicated for the management of severe chronic pain in patients who are intolerant or refractory to other treatment, including systemic analgesics, or adjunctive therapies, and in whom intrathecal therapy is warranted.
- PHARMACOLOGY: Ziconotide is bound to N-type voltage-sensitive calcium channels located on the primary nociceptive afferent nerves in the superficial layers of the dorsal horn in the spinal cord. It blocks depolarization-induced increases in presynaptic intracellular calcium, which controls excitatory neurotransmitter release into the synaptic cleft. Ziconotide is derived from the venom of the marine snail Conus magus.
- EPIDEMIOLOGY: Overdose is rare.
- WITH THERAPEUTIC USE
- COMMON: Dizziness, nausea, confusion, somnolence, nystagmus, and asthenia. OTHERS: Nausea, vomiting, anorexia, constipation, diarrhea, taste perversion, cognitive impairment, agitation, stupor, headache, dizziness, asthenia, ataxia, delirium, dysarthria, tremor, hallucinations, urinary retention, hypotension, peripheral edema, atrial fibrillation, abnormal ECG, blurred vision, elevated liver enzymes, muscle spasm, pain in limb, rhabdomyolysis, sinusitis, and fever.
- WITH POISONING/EXPOSURE
- Ziconotide overdose information is limited. Exaggerated pharmacologic effects (ie, ataxia, nystagmus, dizziness, stupor, unresponsiveness, spinal myoclonus, confusion, hypotension, nausea, and vomiting) are expected to occur following ziconotide intrathecal doses greater than the maximum recommended dose of 19.2 mcg/day.
© 2011-2020 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.